Veerabhadra R. Vulupala

MedicineComputer ScienceChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease”.

A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c00221

N/A

0DataRank · unranked

25 citations

Sandeep Atla, Namir Shaabani, Veerabhadra R. Vulupala, Kai S. Yang, Yugendar R. Alugubelli +13 more

Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.29.560163

N/A

0DataRank · unranked

9 citations

Jing Xiao, Kaustav Khatua, Sathish Kumar, Yuying Ma, R. Xinyu +8 more

A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.17.524469

N/A

0DataRank · unranked

4 citations

Sandeep Atla, Namir Shaabani, Veerabhadra R. Vulupala, Kai S. Yang, Yugendar R. Alugubelli +13 more

An Azapeptide Platform in Conjunction with Covalent Warheads to Uncover High-Potency Inhibitors for SARS-CoV-2 Main Protease

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.11.536467

N/A

0DataRank · unranked

3 citations

Yugendar R. Alugubelli, Kai S. Yang, Veerabhadra R. Vulupala, Lauren R. Blankenship, Demonta Coleman +14 more

Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.3c02416

N/A

0DataRank · unranked

75 citations

Jing Xiao, Kaustav Khatua, Sathish Kumar, Long Sun, Yuying Ma +10 more

SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the Enzyme

ACS Medicinal Chemistry Letters(2024)10.1021/acsmedchemlett.4c00146

N/A

0DataRank · unranked

12 citations

Kai S. Yang, Veerabhadra R. Vulupala, Yugendar R. Alugubelli, Kaustav Khatua, Demonta Coleman +8 more

Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors

Antiviral Research(2024)10.1016/j.antiviral.2024.105874

N/A

0DataRank · unranked

11 citations

Yugendar R. Alugubelli, Kai S. Yang, Veerabhadra R. Vulupala, Lauren R. Blankenship, Demonta Coleman +15 more

Facile One-Pot Synthesis of α-Boryl Ureas and Carbamates via in situ Generated α-Boryl Isocyanates to Uncover a Potent Main Protease Inhibitor

ChemRxiv(2025)10.26434/chemrxiv-2025-glhfk

N/A

0DataRank · unranked

0 citations

Satyanarayana Nyalata, Sophea Pa, Disni Gunasekera, Veerabhadra R. Vulupala, N. Arjunreddy Mallampudi +2 more